MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹273 Cr | ₹205 Cr | ₹84 Cr | ₹57 Cr | ₹24 Cr |
What is the latest Total Non-Current Liabilities ratio of MARKSANS PHARMA ?
Year | Total Non-Current Liabilities |
---|---|
Mar2025 | ₹273 Cr |
Mar2024 | ₹205 Cr |
Mar2023 | ₹84 Cr |
Mar2022 | ₹57 Cr |
Mar2021 | ₹24 Cr |
How is Total Non-Current Liabilities of MARKSANS PHARMA Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹273 Cr | 33.00 | |
Mar2024 | ₹205 Cr | 143.34 | |
Mar2023 | ₹84 Cr | 47.80 | |
Mar2022 | ₹57 Cr | 140.72 | |
Mar2021 | ₹24 Cr | - |
Compare Total Non-Current Liabilities of peers of MARKSANS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MARKSANS PHARMA | ₹10,702.3 Cr | -4.1% | -13% | 13% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹416,273.0 Cr | 1.7% | 2% | -0.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹176,604.0 Cr | 0.4% | -2% | 37.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹126,316.0 Cr | 6% | 10.5% | 13.6% | Stock Analytics | |
CIPLA | ₹125,993.0 Cr | 6.8% | 4.6% | -0.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,795.0 Cr | 4.2% | 1.3% | -6.7% | Stock Analytics |
MARKSANS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MARKSANS PHARMA | -4.1% |
-13% |
13% |
SENSEX | -1.5% |
-2.5% |
0.2% |
You may also like the below Video Courses